| Pharmacotherapy for Nicotine Dependence 1 JE Henningfield, RV Fant, AR Buchhalter, ML Stitzer CA: a cancer journal for clinicians 55 (5), 281-299, 2005 | 358 | 2005 |
| Do prescription monitoring programs impact state trends in opioid abuse/misuse? LM Reifler, D Droz, JE Bailey, SH Schnoll, R Fant, RC Dart, ... Pain medicine 13 (3), 434-442, 2012 | 324 | 2012 |
| Pharmacokinetics and pharmacodynamics of moist snuff in humans RV Fant, JE Henningfield, RA Nelson, WB Pickworth Tobacco Control 8 (4), 387-392, 1999 | 208 | 1999 |
| Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability CT Sweeney, RV Fant, KO Fagerstrom, JF McGovern, JE Henningfield CNS drugs 15, 453-467, 2001 | 185 | 2001 |
| Acute and residual effects of marijuana in humans RV Fant, SJ Heishman, EB Bunker, WB Pickworth Pharmacology Biochemistry and Behavior 60 (4), 777-784, 1998 | 159 | 1998 |
| The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research JE Henningfield, RV Fant, DW Wang Psychopharmacology 235, 573-589, 2018 | 150 | 2018 |
| Pharmacodynamic effects of new de-nicotinized cigarettes WB Pickworth, RA Nelson, MS Rohrer, RV Fant, JE Henningfield Nicotine & Tobacco Research 1 (4), 357-364, 1999 | 145 | 1999 |
| Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions EJ Cone, RV Fant, JM Rohay, YH Caplan, M Ballina, RF Reder, ... Journal of analytical toxicology 28 (7), 616-624, 2004 | 131 | 2004 |
| Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases EJ Cone, RV Fant, JM Rohay, YH Caplan, M Ballina, RF Reder, D Spyker, ... Journal of Analytical Toxicology 27 (2), 57-67, 2003 | 121 | 2003 |
| A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches RV Fant, JE Henningfield, S Shiffman, KR Strahs, DP Reitberg Pharmacology Biochemistry and Behavior 67 (3), 479-482, 2000 | 109 | 2000 |
| Nicotine concentration, smoke pH and whole tobacco aqueous pH of some cigar brands and types popular in the United States JE Henningfield, RV Fant, A Radzius, S Frost Nicotine & tobacco research 1 (2), 163-168, 1999 | 106 | 1999 |
| Smokeless tobacco: an addicting drug JE Henningfield, RV Fant, SL Tomar Advances in dental research 11 (3), 330-335, 1997 | 98 | 1997 |
| Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status AR Buchhalter, RV Fant, JE Henningfield Drugs 68, 1067-1088, 2008 | 72 | 2008 |
| Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans WB Pickworth, RV Fant Psychoneuroendocrinology 23 (2), 131-141, 1998 | 71 | 1998 |
| Nicotine delivery systems S Shiffman, RV Fant, AR Buchhalter, JG Gitchell, JE Henningfield Expert Opinion on Drug Delivery 2 (3), 563-577, 2005 | 69 | 2005 |
| Nicotine replacement therapy RV Fant, LL Owen, JE Henningfield Primary care: clinics in office practice 26 (3), 633-652, 1999 | 68 | 1999 |
| Effects of abused drugs on psychomotor performance. WB Pickworth, MS Rohrer, RV Fant Experimental and clinical psychopharmacology 5 (3), 235, 1997 | 65 | 1997 |
| Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability MF Stiles, LR Campbell, DW Graff, BA Jones, RV Fant, JE Henningfield Psychopharmacology 234, 2643-2655, 2017 | 56 | 2017 |
| Pharmacotherapy for tobacco dependence RV Fant, AR Buchhalter, AC Buchman, JE Henningfield Nicotine Psychopharmacology, 487-510, 2009 | 52 | 2009 |
| Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal. WB Pickworth, RV Fant, MF Butschky, JE Henningfield Journal of Pharmacology and Experimental Therapeutics 279 (2), 450-456, 1996 | 51 | 1996 |
